DFDA

Lisinopril

Treatment for Acute Glomerulonephritis

Typical Dosage: 5-40 mg daily

Effectiveness
80%
Safety Score
70%
Clinical Trials
400
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
5-40 mg daily
Time to Effect
Days to 1-2 weeks
Treatment Duration
Long-term, often lifetime
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$300
Side Effect Mgmt:$75
Total Annual:$450
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$180/QALY
QALYs Gained
2.5
Outcome-Based Costs
Cost per Responder
$600
Comparison vs Beta-blockers or Calcium Channel Blockers
Cost Difference
$0/year
Same cost
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Lisinopril Outcomes

for Acute Glomerulonephritis

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+75%
Common Side Effects
Cough
+10%
Dizziness/Hypotension
+7%
Hyperkalemia
+7%
Angioedema
+1%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov